https://brandessenceresearch.com/ Logo
Events
Register
Login
Home

Pigmentation Disorder Treatment Market

Pigmentation Disorder Treatment Market Size, Share & Trends Analysis Report

Pigmentation Disorder Treatment Market By Disease Type (Melasma, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation), By Treatment Type (Pharmacological Treatment, Cosmetic Treatment), By Distribution Channel (Dermatology Clinics, Aesthetic Clinics , Drugstores And Cosmetic Stores, E-Commerce And Others), Industry Analysis, Trends, And Forecast 2019

MethodologyRequest MethodologyMethodologyDownload Sample
Published
Report ID : BMRC 251
Number of pages : 200
Published Date : May 2023
Category : Healthcare
Delivery Timeline : 48 hrs
PricingPricing

Pigmentation Disorder Treatment Market is valued around USD 5223.5 Million in 2018 and expected to reach USD 8644.9 Million by 2025 with the CAGR of 6.5% over the forecast period. Increasing prevalence of skin disorders and increase in research and development are the key drivers for Global Pigmentation Disorder Treatment Market.

Market Analysis of Pigmentation Disorder Treatment

Pigmentation Disorder Treatment market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about pigmentation disorder treatment market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with disease type, treatment type and distribution channel.

Pigmentation disorders are a condition which refers to the lightening or darkening of skin color than normal skin color. Pigmentation is mainly caused due to the presence of a chemical substance called melanin which is responsible for the complexion. Melanin protects our skin from sun light to penetrate deep in the skin. In some cases over production of melanin leads to the dark skin color and less production leads to the light skin color.  People over exposed with sun rays, stress, hormonal changes and others leads to the pigmentation disorders in some cases it is genetic or hereditary.

There are various factors driving the growth of the pigmentation disorder treatment market, some of the major factors driving the growth of the market are increased prevalence of skin disorders and changes associated with lifestyle over the period of time. In addition, increase in the demand for cosmetic treatments due to the rise in disposable income of people is also expected to promote the growth of pigmentation disorder treatment market over the forecast period. Furthermore, presence of different treatment preferences and increase in research and development activities are expected to drive the growth of pigmentation disorder treatment market over the forecast period. However, high cost of cosmetic surgery and contradictions regarding adverse effects of some medications may hamper the growth of pigmentation disorders treatment market.

Global pigmentation disorder treatment market report covers prominent players like Episciences, Inc., Allergan, Inc., La Roche-Posay, SkinCeuticals International, Obagi Medical Products Inc., Bayer AG, Pierre Fabre Laboratories, Alvogen, Inc. and others.

Market Segmentation –

By Disease Type

  • Melasma
  • Vitiligo
  • Albinism
  • Post-inflammatory hyperpigmentation
  • Other

By Treatment Type

  • Pharmacological Treatment
  • Cosmetic Treatment

By Distribution Channel

  • Dermatology Clinics
  • Aesthetic Clinics
  • Drugstores and Cosmetic Stores
  • E-commerce and Others

By Region

  • North America
    • U.S
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key Players

  • Allergan Inc.
  • La Roche-Posay
  • SkinCeuticals International
  • Obagi Medical Products Inc.
  • L'Oreal SA
  • Dermamed
  • Merz GmbH & Co. KGaA
  • SkinCeuticals International
  • LumenisBe Ltd.
  • Mesoestetics
SUMMARY
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
Segmentation
Segments

By Disease Type

  • Melasma
  • Vitiligo
  • Albinism
  • Post-inflammatory hyperpigmentation
  • Other

By Treatment Type

  • Pharmacological Treatment
  • Cosmetic Treatment

By Distribution Channel

  • Dermatology Clinics
  • Aesthetic Clinics
  • Drugstores and Cosmetic Stores
  • E-commerce and Others
Country
Regions and Country

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Company
Key Players
  • Allergan Inc.
  • La Roche-Posay
  • SkinCeuticals International
  • Obagi Medical Products Inc.
  • L'Oreal SA
  • Dermamed
  • Merz GmbH & Co. KGaA
  • SkinCeuticals International
  • LumenisBe Ltd.
  • Mesoestetics

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®

PaymentModes